# Immunosuppression Management in Renal Transplant Recipients With Transplant Excellence Based on TruGraf Test

> **NCT04670926** · NA · UNKNOWN · sponsor: **Transplant Genomics, Inc.** · enrollment: 75 (estimated)

## Conditions studied

- Kidney Transplant Rejection
- Immunosuppression

## Interventions

- **DIAGNOSTIC_TEST:** TruGraf
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT04670926
- **Lead sponsor:** Transplant Genomics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-03
- **Primary completion:** 2023-06-03
- **Final completion:** 2023-09-30
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2021-08-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04670926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04670926, "Immunosuppression Management in Renal Transplant Recipients With Transplant Excellence Based on TruGraf Test". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04670926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*